Veterinary Healthcare Market Size, Trends, Industry Share, Key Players and Forecast 2025-2033

MARKET OVERVIEW

The global Veterinary Healthcare Market was valued at USD 46.4 Billion in 2024 and is expected to reach USD 83.2 Billion by 2033, growing at a CAGR of 6.7% between 2025 and 2033. North America dominates the market with over 40.6% share in 2024 due to factors such as rising pet ownership, increased concerns for animal health, and adoption of veterinary health information systems. The growth is further driven by rising zoonotic diseases, livestock demand, and advanced healthcare technologies.

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

VETERINARY HEALTHCARE MARKET KEY TAKEAWAYS

• Current Market Size: USD 46.4 Billion in 2024
• CAGR: 6.7% during 2025-2033
• Forecast Period: 2025-2033
• North America holds over 40.6% market share in 2024.
• Increasing zoonotic, food-borne, and chronic disease prevalence boosts veterinary healthcare demand.
• Rising pet adoption rates lead to higher demand for advanced veterinary services and pet insurance.
• Livestock population growth escalates the need for veterinary services to maintain productivity and control diseases.
• Introduction of veterinary health information systems improves diagnostics and treatment outcomes.

Sample Request Link: https://www.imarcgroup.com/veterinary-healthcare-market/requestsample

MARKET GROWTH FACTORS

The global veterinary healthcare market is on the rise due to the heightened concern over animal health and welfare. One of the key factors driving this trend is the increasing number of pets, particularly in the developed countries. Where more and more households consider pets as family members, the demand for sophisticated veterinary services, preventive treatments, and pet insurance is also growing. Furthermore, the rising number of livestock to cater to the worldwide demand for animal products like meat, milk, and eggs is compelling the farmers to invest in veterinary care for the purpose of productivity enhancement and disease control management.

The market growth is considerably affected by the coming of zoonotic diseases like avian flu. The United States Centers for Disease Control and Prevention (CDC) states that 80% of the potential bioterrorism agents are zoonotic diseases, among them being anthrax and plague, which underlines the role of animal health in public safety and global biosecurity. Thus, the situation intensifies the need for animal vaccinations and diagnostic services, especially in North America, where the great amount of money spent on pet healthcare also serves as a stimulus for the market.

The role of technological advancements in promoting the market expansion is very significant. New techniques, such as telemedicine, pet wearables, and highly precise diagnostic instruments, make the quality and accessibility of service better. Government policies that are encouraging, the growing pet insurance availability, and the rising awareness of human-transmissible diseases from pets help to develop the market in the leading countries, for example, the United States, thus enhancing the comprehensive veterinary care offerings and making the consumers more willing to spend on animal health.

MARKET SEGMENTATION

Analysis by Product:

• Therapeutics: Include vaccines, parasiticides, anti-infectives, medical feed additives, and others. These are used to treat and prevent a variety of animal health issues, accounting for the largest market share of 78.9% in 2024.
• Diagnostics: Comprise immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, and others. These are essential for accurate disease detection and monitoring.

Analysis by Animal Type:

• Dogs and Cats: Covers veterinary healthcare services such as check-ups, vaccinations, surgeries, medications, and preventive care tailored for common domestic pets.
• Horses: Not specifically described in the source.
• Ruminants: Includes herd health management, reproductive services, nutrition assessment, and disease treatment for animals like cattle, sheep, and goats used for meat, milk, and wool.
• Swine: Focuses on health management for pigs, including disease prevention, vaccination, nutrition, and treatment of swine-specific conditions.
• Poultry: Entails disease control, vaccination, nutritional guidance, and health management for birds raised for meat and egg production.
• Others: Not detailed in the source.

Analysis by End User:

• Veterinary Hospitals: Provide comprehensive services including check-ups, surgeries, diagnostic imaging, laboratory testing, dental care, and emergency services, often with specialists on staff.
• Veterinary Clinics: Not specifically described in the source.
• Veterinary Laboratory Testing Services: Not specifically described in the source.
• Others: Not detailed in the source.

REGIONAL INSIGHTS

North America dominates the veterinary healthcare market in 2024 with over 40.6% market share. The region benefits from high pet ownership rates, advanced veterinary healthcare infrastructure, and pet owners' preference for proactive and comprehensive animal care, including preventive services and nutritional guidance. This strong market presence is supported by extensive veterinary hospitals, clinics, and specialized centers equipped with state-of-the-art technology and skilled professionals.

RECENT DEVELOPMENTS & NEWS

• December 2024: Zoetis announced the launch of Vetscan OptiCell™, an AI-powered screenless hematology analyzer at the Veterinary Meeting & Expo (VMX). It delivers fast and accurate CBC analysis with minimal maintenance.
• October 2024: Panav Biotech launched Maropitine Injection, a treatment for nausea and vomiting in dogs and cats addressing motion sickness, chemotherapy-induced nausea, and post-anaesthesia vomiting.
• July 2024: The Animal Care Organization (TACO) in Faridabad, Haryana established a veterinary clinic with a mobile health van and animal birth control unit, offering surgeries, diagnostics, vaccinations, and population control services.
• July 2024: Elanco Animal Health partnered with a biotechnology company to develop innovative animal healthcare solutions aiming to improve treatment options.

KEY PLAYERS

• Animalcare Group plc
• Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
• Ceva Animal Health LLC
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Heska Corporation
• IDEXX Laboratories Inc.
• INDICAL Bioscience GmbH (Vimian Group)
• Merck & Co. Inc.
• Norbrook Laboratories Ltd
• Vetoquinol India Animal Health Pvt Ltd (Vétoquinol S.A.)
• Virbac
• Zoetis Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

ABOUT US

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

CONTACT US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302